Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01833026 · ClinicalTrials.gov registry record · NA

COPD Assessment and Management Bundle Versus Usual Care

A NA study of Chronic Obstructive Pulmonary Disease, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT01833026: Completed NA study of Chronic Obstructive Pulmonary Disease, sponsored by University of Illinois at Chicago.

NCT01833026 is a NA study of Chronic Obstructive Pulmonary Disease that has completed, run by University of Illinois at Chicago. The registered enrollment target is 56 participants, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01833026, a NA study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory (lung) disease that makes it harder to breathe over time. To date, there is no cure for COPD, but it can be managed when diagnosed and proper medical care is provided. The purpose of this study is to determine if diagnosis and guided therapy with the use of spirometry is related to better patient outcomes (the condition of a patient's health) compared to usual care which may or may not include the use of spirometry. Spirometry is a standardized test used in medical practice that measures how much air your lungs can hold and how forcefully you can breathe out. For this study, the investigators will compare two groups: 1) intervention (treatment) group and 2) usual care group (control). The intervention group will have a spirometry test and the results will be provided to the primary care physician. The usual care group will not initially have a spirometry test. Both groups will be followed for outcomes.

Primary Outcome

accuracy of diagnosis was the outcome measure. The results of the spirometry test (done in the beginning for the intervention group and ant the end of 1 year for the usual care groups) were reviewed in conjunction with the initial physician diagnosis of COPD and/or asthma to confirm whether the diagnosis was accurate, not accurate, or indeterminate. Accuracy of diagnosis of COPD was determined by spirometry results if the FEV1/FVC ratio was \<0.7.

Interventions

  • DEVICE Spirometry test
  • DRUG Levalbuterol

Study Locations (1)

Illinois

  • University of Illinois - Chicago

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2013-03
Est. Completion 2016-05
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT01833026 record still lists

NCT01833026 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 2 interventions - of which Spirometry test is the first listed.

NCT01833026 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT01833026 about?

NCT01833026 is a clinical study titled "COPD Assessment and Management Bundle Versus Usual Care". Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory (lung) disease that makes it harder to breathe over time. To date, there is no cure for COPD, but it can be managed when diagnosed and proper medical care is provided. The purpose of this study is to determine if diagnosis an...

What is the current status of trial NCT01833026?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2013-03. Estimated completion is 2016-05.

What conditions does trial NCT01833026 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

What interventions are being tested in trial NCT01833026?

The interventions under investigation include: Spirometry test (DEVICE), Levalbuterol (DRUG).

Who is sponsoring clinical trial NCT01833026?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01833026 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01833026's enrollment target sits among peer trials

56 61st of 86 higher than 26 of 86 other Chronic Obstructive Pulmonary Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01833026, the US trial registry maintained by the National Library of Medicine. NCT01833026 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.